Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 6 studies | 30% ± 14% | |
ciliated cell | 5 studies | 31% ± 8% | |
astrocyte | 4 studies | 24% ± 7% | |
goblet cell | 4 studies | 22% ± 4% | |
basal cell | 4 studies | 27% ± 11% | |
endothelial cell | 3 studies | 21% ± 3% | |
glutamatergic neuron | 3 studies | 36% ± 3% | |
transit amplifying cell | 3 studies | 25% ± 9% | |
erythroblast | 3 studies | 34% ± 14% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 23% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 2648.33 | 21 / 21 | 100% | 28.63 | 504 / 504 |
esophagus | 100% | 4337.89 | 1445 / 1445 | 100% | 29.85 | 183 / 183 |
intestine | 100% | 2538.18 | 966 / 966 | 100% | 22.44 | 527 / 527 |
prostate | 100% | 4744.55 | 245 / 245 | 100% | 42.33 | 502 / 502 |
stomach | 100% | 2027.57 | 359 / 359 | 100% | 21.45 | 286 / 286 |
thymus | 100% | 3993.55 | 653 / 653 | 100% | 31.37 | 605 / 605 |
uterus | 100% | 3718.18 | 170 / 170 | 100% | 35.35 | 459 / 459 |
lung | 100% | 2543.98 | 578 / 578 | 100% | 29.10 | 1154 / 1155 |
breast | 100% | 2268.45 | 459 / 459 | 100% | 26.69 | 1116 / 1118 |
ovary | 100% | 1774.79 | 180 / 180 | 100% | 23.34 | 429 / 430 |
pancreas | 100% | 1658.02 | 328 / 328 | 99% | 20.32 | 177 / 178 |
brain | 99% | 1573.71 | 2624 / 2642 | 100% | 19.29 | 705 / 705 |
skin | 100% | 3759.36 | 1809 / 1809 | 99% | 22.13 | 467 / 472 |
kidney | 100% | 1597.20 | 89 / 89 | 98% | 14.19 | 885 / 901 |
adrenal gland | 100% | 1473.98 | 258 / 258 | 93% | 11.39 | 215 / 230 |
liver | 100% | 1080.82 | 225 / 226 | 88% | 9.85 | 357 / 406 |
adipose | 100% | 2147.70 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3909.16 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 26.15 | 29 / 29 |
spleen | 100% | 2612.67 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 41.26 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 26.67 | 1 / 1 |
muscle | 100% | 1443.94 | 800 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 1414.63 | 850 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 92% | 1628.27 | 855 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 91% | 11.71 | 73 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0043516 | Biological process | regulation of DNA damage response, signal transduction by p53 class mediator |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0051301 | Biological process | cell division |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0006338 | Biological process | chromatin remodeling |
GO_0018026 | Biological process | peptidyl-lysine monomethylation |
GO_1901796 | Biological process | regulation of signal transduction by p53 class mediator |
GO_0007076 | Biological process | mitotic chromosome condensation |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_2000042 | Biological process | negative regulation of double-strand break repair via homologous recombination |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005700 | Cellular component | polytene chromosome |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0140939 | Molecular function | histone H4 methyltransferase activity |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0016278 | Molecular function | lysine N-methyltransferase activity |
GO_0140944 | Molecular function | histone H4K20 monomethyltransferase activity |
GO_0042054 | Molecular function | histone methyltransferase activity |
GO_0042799 | Molecular function | histone H4K20 methyltransferase activity |
GO_0016279 | Molecular function | protein-lysine N-methyltransferase activity |
GO_0140110 | Molecular function | transcription regulator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | KMT5A |
Protein name | N-lysine methyltransferase KMT5A (EC 2.1.1.-) (H4-K20-HMTase KMT5A) (Histone-lysine N-methyltransferase KMT5A) (EC 2.1.1.361) (Lysine N-methyltransferase 5A) (Lysine-specific methylase 5A) (PR/SET domain-containing protein 07) (PR-Set7) (PR/SET07) (SET domain-containing protein 8) Lysine methyltransferase 5A [histone H4]-lysine(20) N-methyltransferase (EC 2.1.1.361) |
Synonyms | PRSET7 SETD8 SET07 SET8 |
Description | FUNCTION: Protein-lysine N-methyltransferase that monomethylates both histones and non-histone proteins . Specifically monomethylates 'Lys-20' of histone H4 (H4K20me1) . H4K20me1 is enriched during mitosis and represents a specific tag for epigenetic transcriptional repression . Mainly functions in euchromatin regions, thereby playing a central role in the silencing of euchromatic genes . Required for cell proliferation, probably by contributing to the maintenance of proper higher-order structure of DNA during mitosis . Involved in chromosome condensation and proper cytokinesis . Nucleosomes are preferred as substrate compared to free histones . Mediates monomethylation of p53/TP53 at 'Lys-382', leading to repress p53/TP53-target genes . Plays a negative role in TGF-beta response regulation and a positive role in cell migration . . |
Accessions | ENST00000437502.1 ENST00000402868.8 [Q9NQR1-2] Q9NQR1 E3VVS3 F8WC45 ENST00000437519.5 C9JKQ0 |